Skip to content
OpenCapital
Get started

Bausch + Lomb BLCO EPS (Diluted)

EPS (Diluted) at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$2.14-52.9%
The Cooper Companies, Inc. logo
The Cooper Companies, Inc.COO
-$0.40-191%
Glaukos logo
GlaukosGKOS
-$0.34-6.3%
AbbVie logo
AbbVieABBV
$0.39-45.8%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$6.75-7.2%
Solventum logo
SolventumSOLV
$0.07-91.0%

Other financials

Income statement

See full
Revenue$1.2B+9.4%
Operating income$33.0M+140%
Net income-$71.0M+66.5%

Balance sheet

See full
Cash & equivalents$279.0M+29.8%
Total debt$5.0B+4.3%
Total equity$6.4B+0.3%
Total assets$13.8B+2.6%

Cash flow

See full
Operating cash flow$32.0M+228%
CapEx$100.0M-9.1%
Free cash flow-$68.0M+49.6%

Valuation

See full
Market cap$5.3B+10.2%
Enterprise value$10.06B+6.9%
P/S1×0.0×

Profitability

See full
Operating margin4.4%+2.9pp
Net margin-4.2%-1.3pp
FCF margin-3.4%0.0pp

Returns & leverage

See full
Return on equity-3.4%-0.9pp
Debt / equity0.8×0.0×
Current ratio1.5×0.0×

Where this comes from

Reported directly by Bausch + Lomb in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The official record: Bausch + Lomb’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch + Lomb's eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bausch + Lomb's EPS (diluted)?
Bausch + Lomb (BLCO) reported EPS (diluted) of -$0.20 in Q1 2026.
How has Bausch + Lomb's EPS (diluted) changed year-over-year?
Bausch + Lomb's EPS (diluted) increased by 66.7% year-over-year, from -$0.60 to -$0.20.
What is the long-term trend for Bausch + Lomb's EPS (diluted)?
Over 4 years (2021 to 2025), Bausch + Lomb's EPS (diluted) has grown at a 18.1% compound annual growth rate (CAGR), from $0.53 to -$1.03.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.